NFKB1 and cancer: The NF-κB signaling pathway remains a very attractive target for pharmacological intervention because it has crucial functions in human health and disease, particularly in inflammatory diseases and cancers (Hayden and Ghosh, 2008; Perkins, 2007; Smale, 2011).